Disaggregation of Hepatobiliary Cancer Mortality Among Asian Americans: Analysis of NVSS Mortality Data
Cancer Medicine · 2025
DOI: 10.1002/cam4.71259 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Anna Park und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Georgetown University, Washington DC, USA. Hauptthemen laut MEDLINE: Asian, Liver Neoplasms, Biliary Tract Neoplasms. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NHLBI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Background
Asian Americans (AAs) are a diverse population, and aggregation of AA health data in national reports conceals significant differences between AA subgroups. As hepatobiliary cancer rates increase globally, a greater understanding of hepatobiliary mortality among AA subgroups could motivate precision intervention and screening programs.
Methods
Using national mortality data from 2005 to 2020, we report age‐adjusted mortality rates, standardized mortality ratios, and annual percent change for hepatocellular carcinoma (HCC), nonspecified liver cancer (NOS), intrahepatic cholangiocarcinoma (ICC), extrahepatic cholangiocarcinoma (ECC), and gallbladder cancer (GBC) using national mortality data for the six largest AA subgroups (Asian Indian, Chinese, Filipino, Japanese, Korean, and Vietnamese) compared to non‐Hispanic White people (NHW).
Results
All AA subgroups (except Asian Indians) had significantly higher hepatobiliary cancer mortality than NHW people. Vietnamese people demonstrated the highest mortality from HCC (7.65 per 100,000) and nonspecified liver cancer (5.57 per 100,000), while Korean people had the highest mortality from the biliary tract cancers: ICC (3.10 per 100,000), GBC (0.72 per 100,000), and ECC (0.97 per 100,000). Notably, ICC mortality increased across the study period. Across all subgroups, male individuals had significantly higher hepatobiliary cancer mortality than female individuals, with differences being largest for HCC and nonspecified liver cancer.
Conclusions
Differences in mortality across hepatobiliary cancer types demonstrate the importance of analyzing subtypes separately. These differences also highlight the importance of developing ethnically targeted screening, prevention strategies, and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Georgetown University, Washington DC, USA.
- Department of Physics, Princeton University, Princeton, New Jersey, USA.
- Department of Medicine, University of Nevada, Reno School of Medicine, Reno, Nevada, USA.
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
- Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
- Center for Asian Health Research and Education, Stanford University School of Medicine, Stanford, California, USA.
ORCID-Profile: Xinran Qi, Adrian M Bacong
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Park, A., Vodinh-Ho, A., Rok, I., Qi, X., Hung, G. A., Kikuta, N., Jamal, A., Kim, G. S., Palaniappan, L. P., Srinivasan, M., Huang, R. J., & Bacong, A. M. (2025). Disaggregation of Hepatobiliary Cancer Mortality Among Asian Americans: Analysis of NVSS Mortality Data. Cancer Medicine. https://doi.org/10.1002/cam4.71259
Vancouver
Park A, Vodinh-Ho A, Rok I, Qi X, Hung GA, Kikuta N, et al. Disaggregation of Hepatobiliary Cancer Mortality Among Asian Americans: Analysis of NVSS Mortality Data. Cancer Medicine. 2025. doi:10.1002/cam4.71259
BibTeX
@article{Park2025,
author = {Park, Anna and Vodinh-Ho, Andrew and Rok, Ivory and Qi, Xinran and Hung, George A and Kikuta, Nicholas and Jamal, Armaan and Kim, Gloria S and Palaniappan, Latha P and Srinivasan, Malathi and Huang, Robert J and Bacong, Adrian M},
title = {Disaggregation of Hepatobiliary Cancer Mortality Among Asian Americans: Analysis of NVSS Mortality Data},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.71259}
}
EUVIMED